Private intravitreal eye injections (anti-VEGF) cost in the UK: 2026 price guide

Private intravitreal injections place a medicine into the jelly of the eye to treat wet age-related macular degeneration, diabetic macular oedema and retinal vein occlusion, usually given repeatedly over months or years.

The range in the published self-pay lists for intravitreal eye injections (anti-VEGF) was £1,395. That spread reflects different hospitals, different variants and different ideas of what belongs in a package, so the table names each one.

Lists are revised from time to time and sit alongside conditions in the small print. The figures help you see where a quote falls, but they cannot replace your own estimate.

The eye is numbed and cleaned, and a very fine needle places the medicine into the vitreous in a few seconds. A scan before the injection shows whether fluid is present and whether treatment is needed that day.

Because treatment is a series, ask what the quote assumes: a single injection, a loading phase of several, or an ongoing plan with monitoring visits.

Two patients having the same operation or test can receive quite different bills. For intravitreal eye injections (anti-VEGF), these are the factors that most often explain the gap.

• The medicine: licensed anti-VEGF drugs differ widely in price, so the drug is often the largest part of the cost.

• Frequency and duration: monthly or two-monthly injections over a long period make the total far greater than a single figure.

• Imaging at each visit: OCT scans and vision checks are typically part of every appointment.

• Hospital pricing: Nuffield Health Edinburgh lists intravitreal injections at £1,395, which should be read as the price of a single treatment episode.

• Consultant fees and aftercare monitoring.

Ask for the inclusions in writing. For this procedure the usual split between what is covered and what is charged on top looks like this.

Insurers usually cover anti-VEGF treatment for licensed indications, often with a limit on the number of injections or the drug used, so confirm in advance.

Check whether your insurer recognises the exact procedure and the consultant you plan to see, and ask for any excess in writing. Self-funders can usually ask about finance, but terms depend on credit checks and should be read closely.

NHS ophthalmology provides anti-VEGF injections for eligible conditions at no cost to the patient, with national guidance on drugs and criteria, and urgent referral for wet macular degeneration.

Many people consider private care because of NHS waiting times, but the NHS route costs nothing at the point of use and the 18-week standard applies to non-urgent consultant-led pathways. Local performance varies.

You can usually go home straight away, with a gritty feeling for a day, and you should avoid rubbing the eye and watch for warning signs.

The risks below are the ones that can turn a quoted price into a larger bill, so ask how each would be dealt with.

• Rare but serious risks include infection inside the eye and retinal detachment, and eye pain or worsening vision after an injection needs urgent assessment.

• Missing scheduled injections can allow vision loss, so the cost plan should assume a long-term course.

Write the answers down as you go. These are the questions that tend to separate similar-looking quotes for this procedure.

• Does the price include the drug and the scan at each visit?

• How many injections are likely over the first year?

• Which drug is used and why?

• What is the cost if I switch to the NHS or my insurer?

• Is every fee in the quote guaranteed, or could consultant and anaesthetist charges differ from the estimate on the day?